Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 18.76
(-0.74%)
CNY 18.76
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 749.53 Million | 10.53 Billion | 2.82 Billion | 959.09 Million | 181.15 Million | 176.38 Million |
| Cost of Revenue | 309.71 Million | 3.49 Billion | 707.02 Million | 208.99 Million | 46.51 Million | 40.38 Million |
| Gross Profit | 439.81 Million | 7.03 Billion | 2.12 Billion | 750.1 Million | 134.64 Million | 135.99 Million |
| Operating Expenses | 306.69 Million | 1.01 Billion | 410.21 Million | 185.39 Million | 100.12 Million | 71 Million |
| Selling, General and Administrative Expenses | 154.87 Million | 480.97 Million | 223.07 Million | 102.8 Million | 53.71 Million | 44.51 Million |
| Research and Development Expenses | 141.41 Million | 388.36 Million | 132.74 Million | 69.93 Million | 36.95 Million | 27.1 Million |
| Other Expenses | -150.89 Million | 146 Million | 54.38 Million | 12.66 Million | 9.45 Million | 2.53 Million |
| Cost and Expenses | 604.34 Million | 4.5 Billion | 1.11 Billion | 394.39 Million | 146.63 Million | 111.39 Million |
| Operating Income | 145.19 Million | 5.07 Billion | 1.69 Billion | 562.27 Million | 41.53 Million | 68.29 Million |
| Interest Expense | 10.49 Million | 3.42 Million | 2.11 Million | 654.39 Thousand | 95.89 Thousand | 368.42 Thousand |
| Income Tax Expense | 70.67 Million | 695.92 Million | 247.86 Million | 81.07 Million | 4.04 Million | 8.36 Million |
| Earnings before Tax | 139.88 Million | 5.07 Billion | 1.69 Billion | 556.7 Million | 46.55 Million | 70.83 Million |
| Net Income | 74.92 Million | 4.2 Billion | 1.41 Billion | 468.92 Million | 41.52 Million | 61.41 Million |
| Earnings Per Share Basic | 0.33 | 18.08 | 6.68 | 2.27 | 0.20 | 0.35 |
| Earnings Per Share Diluted | 0.33 | 18.08 | 6.68 | 2.27 | 0.20 | 0.35 |
| Weighted Average Shares Outstanding | 227.04 Million | 232.72 Million | 211.7 Million | 206.95 Million | 206.95 Million | 176.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 227.04 Million | 232.72 Million | 211.7 Million | 206.95 Million | 206.95 Million | 176.76 Million |
| Gross Margin | 0.59 | 0.67 | 0.75 | 0.78 | 0.74 | 0.77 |
| EBIT Margin | 0.34 | 0.58 | 0.62 | 0.61 | 0.35 | 0.48 |
| Profit Margin | 0.10 | 0.40 | 0.50 | 0.49 | 0.23 | 0.35 |
| EBITDA | 252.63 Million | 5.14 Billion | 1.72 Billion | 574.59 Million | 64.24 Million | 84.87 Million |
| Earnings Before Tax Margin | 0.19 | 0.48 | 0.60 | 0.59 | 0.23 | 0.39 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 71.05 Million | 92.9 Million | 60.65 Million | 123.6 Million | 749.53 Million | 88.36 Million |
| Cost of Revenue | 39.98 Million | 34.91 Million | 36.4 Million | 18.98 Million | 342.7 Million | 43.75 Million |
| Gross Profit | 31.07 Million | 57.99 Million | 24.24 Million | 104.62 Million | 406.83 Million | 44.61 Million |
| Operating Expenses | 44.28 Million | 66.21 Million | 76.98 Million | 20.77 Million | 306.69 Million | 90.85 Million |
| Selling, General and Administrative Expenses | 13.26 Million | 38.17 Million | 49.8 Million | -38.92 Million | - | 96.31 Million |
| Research and Development Expenses | 31.01 Million | 28.04 Million | 27.18 Million | 34.78 Million | - | 34.69 Million |
| Other Expenses | - | -2.4 Million | -250.39 Thousand | -149.11 Thousand | -5.3 Million | -1.16 Million |
| Cost and Expenses | 84.26 Million | 101.12 Million | 113.39 Million | 39.75 Million | 649.39 Million | 134.6 Million |
| Operating Income | -13.2 Million | -8.21 Million | -52.73 Million | -74.15 Million | 145.19 Million | 48.68 Million |
| Interest Expense | - | - | - | 9.32 Million | 10.49 Million | -1.28 Million |
| Income Tax Expense | 2.76 Million | 6.92 Million | 6.01 Million | 39.14 Million | 70.67 Million | 6.85 Million |
| Earnings before Tax | 10.35 Million | 34.49 Million | 34.12 Million | -74.3 Million | 139.88 Million | 47.51 Million |
| Net Income | 15.77 Million | 33.11 Million | 32.05 Million | -70.37 Million | 74.92 Million | 32.72 Million |
| Earnings Per Share Basic | 0.07 | 0.15 | 0.14 | -0.30 | - | 0.14 |
| Earnings Per Share Diluted | 0.07 | 0.15 | 0.14 | -0.30 | - | 0.14 |
| Weighted Average Shares Outstanding | 222.97 Million | 224.17 Million | 232.52 Million | 232.52 Million | 227.04 Million | 232.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 222.97 Million | 224.17 Million | 232.52 Million | 232.52 Million | 227.04 Million | 232.52 Million |
| Gross Margin | 0.44 | 0.62 | 0.40 | 0.85 | 0.54 | 0.50 |
| EBIT Margin | 0.15 | 0.08 | 0.31 | 0.91 | - | -0.20 |
| Profit Margin | 0.22 | 0.36 | 0.53 | -0.57 | 0.10 | 0.37 |
| EBITDA | 10.35 Million | 7.27 Million | 18.72 Million | 113.06 Million | - | -17.9 Million |
| Earnings Before Tax Margin | -0.19 | -0.09 | -0.87 | -0.60 | 0.19 | 0.55 |
603617
0411
LIXT
GRBMF
000651
6AX